Connection

Hangping Yao to Antibodies, Neutralizing

Back to Details
This is a "connection" page, showing publications Hangping Yao has written about Antibodies, Neutralizing.
Hangping Yao
Connection Strength
0.289
Antibodies, Neutralizing
  1. Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection. Cell Res. 2021 01; 31(1):25-36.
    View in: PubMed
    Score: 0.129
  2. Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40. Cell Physiol Biochem. 2018; 50(3):1055-1067.
    View in: PubMed
    Score: 0.111
  3. Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study. Front Immunol. 2021; 12:708184.
    View in: PubMed
    Score: 0.034
  4. Cross-neutralization of RBD mutant strains of SARS-CoV-2 by convalescent patient derived antibodies. Biotechnol J. 2021 Nov; 16(11):e2100207.
    View in: PubMed
    Score: 0.008
  5. Open-label phase I clinical trial of Ad5-EBOV in Africans in China. Hum Vaccin Immunother. 2017 09 02; 13(9):2078-2085.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.